Skip to main content
. Author manuscript; available in PMC: 2023 Dec 21.
Published in final edited form as: Cell Syst. 2022 Dec 21;13(12):950–973. doi: 10.1016/j.cels.2022.11.005

Table 1.

Summary of published studies on the effect of promoter choice in transgene yields (“Levels”) and sustained expression (“Stability”) over culture time.

Transgene Delivery Method Host Cell Type Transgene Expression Locus of Integration Clone Information Top Three Promoters
Reference
Levels Stability

Lentiviral vector Various Stable Random Polyclonal CAG hEF1α CMV n.d. Qin et al 2010
Lipofectamine 2000 HEK-293F Stable Random or Episomal Polyclonal CAG hEF1α CMV CAG hEF1α CMV Dou et al 2021
Lipofectamine 2000 CHO-K1 Stable Random or Episomal Clonal lines hEF1α CMV CAG Only hEF1α tested X. Wang et al 2017
Lentiviral vector mESC (J1) Transient Random Polyclonal hEF1α CAG hPGK1 Only hEF1α tested Hong et al 2007
Lentiviral vector mESC (JM8.N4) Stable Random Polyclonal n.d. hPGK hEF1α CMV Herbst et al 2012
φC31 integrase mESC (IDG26.10–3) Stable Rosa26 Clonal lines CAG hUbC hEF1α n.d. Chen et al 2011
Electroporation mESC (E14Ju09) Stable Random Clonal lines CAG; mPGK1 n.d. Malaguti et al 2022
Lentiviral vector hESC (SA121; Hues-4) Stable Random Polyclonal hEF1α hACTB PGK hACTB PGK EF1α Norrman et al 2010

For stability in stem cells, the list refers to robust transgene expression over prolonged stem cell maintenance (for differentiation, please see text).

Abbreviations: CAG: CMV early enhancer/β-actin synthetic hybrid promoter; CMV: cytomegalovirus promoter; EF1α: elongation factor 1-alpha promoter; PGK1: phosphoglycerate kinase 1 promoter; UbC: polyubiquitin-C promoter. m or h indicate mouse or human promoter origin and cells respectively; n.d.: not determined.